Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Genetics

Navigating the Multi-System Complications of LPI

At a Glance

Lysinuric protein intolerance (LPI) is a multi-system condition that can cause serious complications in the lungs, immune system, kidneys, and bones. Proactive, routine monitoring by a specialized medical team is essential to detect and manage conditions like PAP, HLH, and kidney dysfunction early.

While Lysinuric protein intolerance (LPI) begins as a metabolic disorder, the y+LAT1 transporter is not just found in the gut and kidneys—it is also present in other cells throughout the body, including immune cells [1]. This means LPI can become a multi-system condition over time.

While reading about these complications can be heavy, remember that early detection through regular monitoring is our most powerful tool [2]. By knowing what to look for, you and your care team can act quickly to manage these systems.

Lung Health: Understanding PAP and ILD

One of the most significant long-term concerns in LPI is Pulmonary Alveolar Proteinosis (PAP) and Interstitial Lung Disease (ILD) [3][4].

  • What it is: In PAP, the air sacs in the lungs (alveoli) become clogged with a protein-rich material that the body’s “cleanup” cells (macrophages) are unable to clear away [3]. This makes it harder for oxygen to reach the blood.
  • Symptoms: Early signs can be subtle, such as getting tired or winded more easily during play (exercise intolerance) or having a persistent dry cough [5][6].
  • Management: Specialists may use whole-lung lavage (a procedure to “wash” the lungs) or emerging therapies like inhaled GM-CSF, which helps activate the cleanup cells [3][7].

Immune Dysregulation: HLH and Autoimmunity

Because the SLC7A7 gene affects how immune cells function, the immune system in LPI can sometimes become “confused” or overactive [1].

  • HLH (Hemophagocytic Lymphohistiocytosis): This is a severe condition where the immune system attacks the body’s own blood cells and organs [8]. Warning signs include unexplained high fevers, an enlarged spleen, and low blood counts (pancytopenia) [8][9].
  • Autoimmune Issues (SLE): Some patients may develop symptoms of Systemic Lupus Erythematosus (SLE), an autoimmune disease where the body attacks its own tissues [4][10]. This may show up as joint pain, skin rashes, or inflammation in various organs [11].

Kidney Health: From Tubulopathy to ESRD

The kidneys are constantly working to filter the blood, and in LPI, the defective transport of amino acids puts a unique strain on them [12].

  • Tubular Dysfunction: The first sign is often “leaky” kidneys, where the tubules fail to reabsorb nutrients (sometimes called Fanconi-like syndrome) [13].
  • Proteinuria: As the condition progresses, you may see mixed proteinuria (different types of protein in the urine) on lab reports [13][14].
  • End-Stage Renal Disease (ESRD): In some cases, the kidneys may eventually lose their ability to function. Kidney transplantation is a feasible and effective option for LPI patients who reach this stage [15][16].

Bone Health: Managing Osteoporosis

Many individuals with LPI experience low bone mineral density, which can lead to osteoporosis (weak or brittle bones) and a higher risk of fractures [17][8].

This is likely due to a combination of the transport defect itself and long-term protein restriction [17]. Your doctor may recommend regular DEXA scans (a type of bone density X-ray) and ensure your child is getting enough calcium and vitamin D [17][18].

Monitoring Framework

To stay ahead of these complications, most metabolic centers follow a proactive monitoring schedule:

  1. Renal: Regular urine tests for beta-2 microglobulin (a sensitive marker of kidney stress) [18].
  2. Pulmonary: Periodic lung function tests or chest imaging, even if there are no symptoms [19].
  3. Immune: Regular blood counts and checking levels of ferritin (a marker of inflammation) [9][8].
  4. Bone: Growth monitoring and bone density scans as the child grows [17].

Common questions in this guide

How does Lysinuric Protein Intolerance affect the lungs?
LPI can lead to Pulmonary Alveolar Proteinosis (PAP) and Interstitial Lung Disease (ILD). This happens when a protein-rich material clogs the air sacs in the lungs, making it harder for oxygen to reach the blood. Early signs include getting winded easily during activity or having a persistent dry cough.
What are the signs of immune system complications in LPI?
Because the genetic defect in LPI affects immune cells, the immune system can become overactive or confused. This can lead to severe conditions like Hemophagocytic Lymphohistiocytosis (HLH) or autoimmune issues resembling lupus. Warning signs include unexplained high fevers, an enlarged spleen, joint pain, and unusual rashes.
Can LPI cause kidney failure?
Yes, the defective transport of amino acids in LPI puts significant strain on the kidneys. This can start as leaky kidneys or protein in the urine and may eventually progress to End-Stage Renal Disease (ESRD). For patients who reach this stage, a kidney transplant is a feasible and effective treatment option.
Why do LPI patients need bone density scans?
Patients with LPI have a higher risk of developing low bone mineral density and osteoporosis, likely due to a combination of the disorder itself and long-term protein restrictions. Doctors typically monitor bone health using regular DEXA scans and by ensuring patients receive adequate calcium and vitamin D.
What routine monitoring is needed for LPI complications?
A proactive monitoring plan typically includes regular lung function tests or chest imaging, urine tests to check for kidney stress, blood counts to monitor immune function and inflammation, and routine bone density scans. This helps specialists catch any changes before symptoms become severe.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How often should my child have a chest CT or lung function test to monitor for silent lung changes?
  2. 2.What specific blood markers (like ferritin or LDH) are you checking to monitor for signs of HLH?
  3. 3.Is my child showing signs of Fanconi-like tubular dysfunction in their recent urine tests?
  4. 4.At what age should we start performing regular DEXA scans to monitor bone density?
  5. 5.Are there any specific 'trigger' symptoms in these other organ systems that should prompt an immediate call to your office?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport.

    Kurko J, Vähä-Mäkilä M, Tringham M, et al.

    Molecular immunology 2015; (67(2 Pt B)):416-25.

    PMID: 26210182
  2. 2

    Title not available

    Jbebli E, Jbeli Y, Amdouni R, et al.

    La Tunisie medicale 2024; (102(5)):284-288 doi:10.62438/tunismed.v102i5.4792.

    PMID: 38801286
  3. 3

    A complicated case of whole-lung lavage: a case report.

    Petrarulo S, Lucchin M, Oldani S, et al.

    Frontiers in medicine 2023; (10()):1225167 doi:10.3389/fmed.2023.1225167.

    PMID: 37538311
  4. 4

    Children with lysinuric protein intolerance: Experience from a lower middle income country.

    Hashmi SB, Ahmed S

    World journal of clinical pediatrics 2022; (11(4)):369-374 doi:10.5409/wjcp.v11.i4.369.

    PMID: 36052112
  5. 5

    Congenital Pulmonary Alveolar Proteinosis: From Birth to Ten-years of Age.

    Alavuk Kundović S, Popović L

    Indian journal of pediatrics 2017; (84(9)):721-723 doi:10.1007/s12098-017-2365-6.

    PMID: 28512724
  6. 6

    Successful haematopoietic stem cell transplantation in a case of pulmonary alveolar proteinosis due to GM-CSF receptor deficiency.

    Frémond ML, Hadchouel A, Schweitzer C, et al.

    Thorax 2018; (73(6)):590-592 doi:10.1136/thoraxjnl-2017-211076.

    PMID: 29263235
  7. 7

    Whole lung lavage and GM-CSF use for pulmonary alveolar proteinosis in an infant with lysinuric protein intolerance: a case report.

    Vojcek E, Krikovszky D, Lódi C, et al.

    Italian journal of pediatrics 2024; (50(1)):111 doi:10.1186/s13052-024-01677-y.

    PMID: 38831374
  8. 8

    Lysinuric protein intolerance mimicking N-acetylglutamate synthase deficiency in a nine-year-old boy.

    Al-Qattan S, Malcolmson C, Mercimek-Andrews S

    Molecular genetics and metabolism reports 2021; (27()):100741 doi:10.1016/j.ymgmr.2021.100741.

    PMID: 33763330
  9. 9

    Lysinuric protein intolerance presenting as pancytopenia and splenomegaly mimicking acute leukaemia: a case report.

    Lokuhewage C, Pathiraja H, Madawala P, et al.

    BMC pediatrics 2023; (23(1)):382 doi:10.1186/s12887-023-04207-7.

    PMID: 37528333
  10. 10

    Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

    Contreras JL, Ladino MA, Aránguiz K, et al.

    Frontiers in pediatrics 2021; (9()):673957 doi:10.3389/fped.2021.673957.

    PMID: 34095032
  11. 11

    Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.

    Li Y, Lv Q, Lu W, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 41821046
  12. 12

    Hyperammonemia in a Child Presenting with Growth Delay, Short Stature, and Diarrhea.

    Almontashiri NAM, Demirbas D, Berry GT, Peake RWA

    Clinical chemistry 2018; (64(8)):1260-1262 doi:10.1373/clinchem.2018.291146.

    PMID: 30054302
  13. 13

    Lysinuric Protein Intolerance: Not Only a Disorder for Pediatric Nephrologists - Case Report.

    Rigoldi M, Mele C, Breno M, et al.

    Nephron 2025; (149(2)):116-124 doi:10.1159/000541363.

    PMID: 39293417
  14. 14

    Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance.

    Nicolas C, Bednarek N, Vuiblet V, et al.

    JIMD reports 2016; (29()):11-17 doi:10.1007/8904_2015_509.

    PMID: 26608393
  15. 15

    Outcomes of kidney transplantation in patients with lysinuric protein intolerance.

    Rautanen T, Ahopelto K, Niinikoski H, et al.

    Clinical kidney journal 2025; (18(1)):sfae373 doi:10.1093/ckj/sfae373.

    PMID: 39802587
  16. 16

    Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.

    IJzermans T, van der Meijden W, Hoeks M, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(4)):493-496 doi:10.1053/j.ajkd.2022.08.019.

    PMID: 36223829
  17. 17

    Delayed skeletal development and IGF-1 deficiency in a mouse model of lysinuric protein intolerance.

    Stroup BM, Li X, Ho S, et al.

    Disease models & mechanisms 2023; (16(8)) doi:10.1242/dmm.050118.

    PMID: 37486182
  18. 18

    Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI.

    Kärki M, Näntö-Salonen K, Niinikoski H, Tanner LM

    JIMD reports 2016; (25()):47-55 doi:10.1007/8904_2015_465.

    PMID: 26122628
  19. 19

    Interstitial Lung Disease in Lysinuric Protein Intolerance Diagnosed by a Transbronchial Lung Cryobiopsy.

    Ono M, Abe M, Saiki A, et al.

    Internal medicine (Tokyo, Japan) 2025; (64(15)):2375-2381 doi:10.2169/internalmedicine.4074-24.

    PMID: 39894503

This page provides information on LPI complications for educational purposes only. Always consult your metabolic team and specialists to create a personalized monitoring and management plan for you or your child.

Get notified when new evidence is published on Lysinuric protein intolerance.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.